|
1
|
Li J, Kang LN and Qiao YL: Review of the
cervical cancer disease burden in mainland China. Asian Pac J
Cancer Prev. 12:1149–1153. 2011.PubMed/NCBI
|
|
2
|
Shepherd JH: Cervical cancer. Best Pract
Res Clin Obstet Gynaecol. 26:293–309. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Shi JF, Canfell K, Lew JB and Qiao YL: The
burden of cervical cancer in China: Synthesis of the evidence. Int
J Cancer. 130:641–652. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Yim EK and Park JS: The role of HPV E6 and
E7 oncoproteins in HPV-associated cervical carcinogenesis. Cancer
Res Treat. 37:319–324. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Li D, Mei H, Qi M, Yang D, Zhao X, Xiang
X, Pu J, Huang K, Zheng L and Tong Q: FOXD3 is a novel tumor
suppressor that affects growth, invasion, metastasis and
angiogenesis of neuroblastoma. Oncotarget. 4:2021–2044. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Wang HY, Lian P and Zheng PS: SOX9, a
potential tumor suppressor in cervical cancer, transactivates
p21WAF1/CIP1 and suppresses cervical tumor growth.
Oncotarget. 6:20711–20722. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Shen L, Huang X, Xie X, Su J, Yuan J and
Chen X: High expression of SOX2 and OCT4 indicates radiation
resistance and an independent negative prognosis in cervical
squamous cell carcinoma. J Histochem Cytochem. 62:499–509. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Ji J, Wei X and Wang Y: Embryonic stem
cell markers Sox-2 and OCT4 expression and their correlation with
WNT signal pathway in cervical squamous cell carcinoma. Int J Clin
Exp Pathol. 7:2470–2476. 2014.PubMed/NCBI
|
|
9
|
Ding Y, Yu AQ, Li CL, Fang J, Zeng Y and
Li DS: TALEN-mediated Nanog disruption results in less
invasiveness, more chemosensitivity and reversal of EMT in HeLa
cells. Oncotarget. 5:8393–8401. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Wang ML, Chiou SH and Wu CW: Targeting
cancer stem cells: Emerging role of Nanog transcription factor.
Onco Targets Ther. 6:1207–1220. 2013.PubMed/NCBI
|
|
11
|
Pei D: Regulation of pluripotency and
reprogramming by transcription factors. J Biol Chem. 284:3365–3369.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Tyagi A, Vishnoi K, Mahata S, Verma G,
Srivastava Y, Masaldan S, Roy BG, Bharti AC and Das BC: Cervical
cancer stem cells selectively overexpress HPV oncoprotein E6 that
controls stemness and self renewal through upregulation of HES1.
Clin Cancer Res. 22:4170–4184. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Oikawa K, Ohbayashi T, Kiyono T, Nishi H,
Isaka K, Umezawa A, Kuroda M and Mukai K: Expression of a novel
human gene, human wings apart-like (hWAPL), is associated with
cervical carcinogenesis and tumor progression. Cancer Res.
64:3545–3549. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Oikawa K, Akiyoshi A, Tanaka M, Takanashi
M, Nishi H, Isaka K, Kiseki H, Idei T, Tsukahara Y, Hashimura N, et
al: Expression of various types of alternatively spliced WAPL
transcripts in human cervical epithelia. Gene. 423:57–62. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Zhou X, Gao Q, Wang J, Zhang X, Liu K and
Duan Z: Linc-RNA-RoR acts as a ‘sponge’ against mediation of the
differentiation of endometrial cancer stem cells by microRNA-145.
Gynecol Oncol. 133:333–339. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Lee JY, Choi YS, Suh JS, Kwon YM, Yang VC,
Lee SJ, Chung CP and Park YJ: Cell-penetrating
chitosan/doxorubicin/TAT conjugates for efficient cancer therapy.
Int J Cancer. 128:2470–2480. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Liu Y, Lv L, Xiao W, Gong C, Yin J, Wang D
and Sheng H: Leptin activates STAT3 and ERK1/2 pathways and induces
endometrial cancer cell proliferation. J Huazhong Univ Sci
Technolog Med Sci. 31:365–370. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Crosbie EJ, Einstein MH, Franceschi S and
Kitchener HC: Human papillomavirus and cervical cancer. Lancet.
382:889–899. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Beaudenon S and Huibregtse JM: HPV E6,
E6AP and cervical cancer. BMC Biochem. 9 Suppl 1:S42008. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Butz K, Ristriani T, Hengstermann A, Denk
C, Scheffner M and Hoppe-Seyler F: siRNA targeting of the viral E6
oncogene efficiently kills human papillomavirus-positive cancer
cells. Oncogene. 22:5938–5945. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Tyagi A, Vishnoi K, Mahata S, Verma G,
Srivastava Y, Masaldan S, Roy BG, Bharti AC and Das BC: Cervical
cancer stem cells selectively overexpress HPV oncoprotein E6 that
controls stemness and self-renewal through upregulation of HES1.
Clin Cancer Res. 22:4170–4184. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Verni F, Gandhi R, Goldberg ML and Gatti
M: Genetic and molecular analysis of wings apart-like (wapl), a
gene controlling heterochromatin organization in Drosophila
melanogaster. Genetics. 154:1693–1710. 2000.PubMed/NCBI
|
|
23
|
Dobie KW, Kennedy CD, Velasco VM, McGrath
TL, Weko J, Patterson RW and Karpen GH: Identification of
chromosome inheritance modifiers in Drosophila melanogaster.
Genetics. 157:1623–1637. 2001.PubMed/NCBI
|
|
24
|
Kueng S, Hegemann B, Peters BH, Lipp JJ,
Schleiffer A, Mechtler K and Peters JM: Wapl controls the dynamic
association of cohesin with chromatin. Cell. 127:955–967. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Kuroda M, Kiyono T, Oikawa K, Yoshida K
and Mukai K: The human papillomavirus E6 and E7 inducible oncogene,
hWAPL, exhibits potential as a therapeutic target. Br J Cancer.
92:290–293. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Wang W, Abbad S, Zhang Z, Wang S, Zhou J
and Lv H: Cell-penetrating peptides for cancer-targeting therapy
and imaging. Curr Cancer Drug Targets. 15:337–351. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Heitz F, Morris MC and Divita G: Twenty
years of cell-penetrating peptides: From molecular mechanisms to
therapeutics. Br J Pharmacol. 157:195–206. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Munyendo WL, Lv H, Benza-Ingoula H, Baraza
LD and Zhou J: Cell penetrating peptides in the delivery of
biopharmaceuticals. Biomolecules. 2:187–202. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Zhang H, Mao Y, Zhang F, Ye C, Tong H, Su
Y and Zhu J: The inhibitory effect of a new scFv/tP protein as
siRNA delivery system to target hWAPL in cervical carcinoma. Mol
Cell Biochem. 391:77–84. 2014. View Article : Google Scholar : PubMed/NCBI
|
